Aly Razek

424 citations
12 papers · 293 · h-index 8

Impact in

Papers in

Aly Razek

12 papers receiving 257 citations

Peers

Aly Razek
Comparison fields: 5 of 55
  • Aquatic Science 44
  • Pulmonary and Respiratory Medicine 160
  • Rheumatology 59
  • Neurology 51
  • Cardiology and Cardiovascular Medicine 75
Replace Masashi Kusakabe with:
Masashi Kusakabe Japan
Arthur Schantz United States
Yoshihiko Nakamoto Japan
Z Voboril Czechia
Daisuke Adachi Japan
B Egloff Switzerland
Mario Stella Italy
J Fujita Japan
Hideto Obata Japan
H Mahera Greece
Aly Razek relative to Masashi Kusakabe Japan Masashi Kusakabe's profile →
Citations per field
00.5×5.4×
Masashi Kusakabe · 1×
Citations per year

Countries citing papers authored by Aly Razek

Since Specialization
Citations

This map shows the geographic impact of Aly Razek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aly Razek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aly Razek more than expected).

Fields of papers citing papers by Aly Razek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aly Razek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aly Razek. The network helps show where Aly Razek may publish in the future.

Co-authors

The 25 scholars most cited alongside Aly Razek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aly Razek Line = papers co-authored together Aly Razek links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1 198073
2 197946
3 197744
4
Survival of hematopoietic and leukemic colony-forming cells in vivo following the administration of daunorubicin or adriamycin.
197229
5 197828
6
Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo.
197426
7 198424
8 197718
9 19782
10 19771
11
Effect of dose fractionation of daunorubicin on survival of leukemic cells.
19801
12 19731

About Aly Razek

Aly Razek is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Public Health, Environmental and Occupational Health, Molecular Biology and Pathology and Forensic Medicine, having authored 12 papers that have together received 293 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (6 papers), Acute Lymphoblastic Leukemia research (4 papers), Management of metastatic bone disease (2 papers), Neuroblastoma Research and Treatments (2 papers), Soft tissue tumor case studies (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Urologic and reproductive health conditions (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Aquatic Science (44 citations), Pulmonary and Respiratory Medicine (160 citations), Rheumatology (59 citations), Neurology (51 citations) and Cardiology and Cardiovascular Medicine (75 citations). Aly Razek has collaborated with scholars based in United States. Frequent co-authors include Teresa J. Vietti, Fred Valeriote, E. Omer Burgert, John M. Kissane, Melvin Tefft, Edmund A. Gehan, Carlos A. Perez, Mark E. Nesbit, Shigeru Tokiwa and Shin‐ichi Teshima. Their work appears in journals such as Cancer, International Journal of Radiation Oncology*Biology*Physics, JNCI Journal of the National Cancer Institute, NIPPON SUISAN GAKKAISHI and Medical and Pediatric Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact